A cohort study of the efficacy of the dienogest and the gonadotropin-releasing hormone agonist in women with adenomyosis and dysmenorrhea.

Miaomiao JiMing YuanXue JiaoQiuju LiYufei HuangJing LiGuoyun Wang

Published in: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology (2021)

Dienogest effectively alleviates the symptoms of dysmenorrhea in patients with adenomyosis, but it cannot improve the anemia or reduce the size of the uterus. GnRH-a is more effective in improving anemia and reducing the uterine volume in patients with adenomyosis. TRIAL REGISTRATION: ChiCTR1900024958.

Keyphrases

chronic kidney disease
iron deficiency
clinical trial
randomized controlled trial
phase ii
physical activity
depressive symptoms